Redcare Pharmacy NV (LON:0RJT)

London flag London · Delayed Price · Currency is GBP · Price in EUR
45.76
+2.10 (4.81%)
At close: Jun 1, 2026
Market Cap830.79M -62.5%
Revenue (ttm)2.68B +21.6%
Net Income-32.66M
EPSn/a
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume52,542
Open43.07
Previous Close43.66
Day's Range44.44 - 47.58
52-Week Range30.20 - 117.70
Beta1.46
Analystsn/a
Price Targetn/a
Earnings DateMay 6, 2026

About Redcare Pharmacy NV

Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is based in Sevenum, the Netherlands. [Read more]

Industry Drug Stores and Proprietary Stores
Founded 2001
Employees 2,163
Stock Exchange London Stock Exchange
Ticker Symbol 0RJT

Financial Performance

In 2025, Redcare Pharmacy NV's revenue was 2.94 billion, an increase of 24.06% compared to the previous year's 2.37 billion. Losses were -37.70 million, -17.14% less than in 2024.

Financial numbers in EUR Financial Statements

News

Redcare Pharmacy NV Earnings Call Transcript: Q1 2026

Q1 2026 saw 18% revenue growth to €849M, with strong Rx and non-Rx performance, improved EBITDA margin, and a rebound in German non-Rx. Guidance remains unchanged amid regulatory uncertainty and early-year volatility, with continued investment in IT and marketing optimization.

27 days ago - Transcripts

Redcare Pharmacy NV Slides: Q1 2026

Redcare Pharmacy NV has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.

27 days ago - Filings

Redcare Pharmacy NV Quarterly report: Q1 2026

Redcare Pharmacy NV has published its Q1 2026 quarterly earnings report on May 6, 2026.

27 days ago - Filings

Redcare Pharmacy NV Earnings release: Q1 2026

Redcare Pharmacy NV released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.

27 days ago - Filings

Redcare Pharmacy NV Earnings Call Transcript: Q4 2025

Full-year revenues rose 24% to EUR 2.9 billion, driven by strong Rx growth and logistics expansion. 2026 guidance targets 13%-15% sales growth, Rx Germany revenues above EUR 670 million, and an adjusted EBITDA margin of at least 2.5%.

3 months ago - Transcripts

Redcare Pharmacy NV Earnings release: Q4 2025

Redcare Pharmacy NV released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.

3 months ago - Filings

Redcare Pharmacy NV Annual report: Q4 2025

Redcare Pharmacy NV has published its Q4 2025 annual report on March 4, 2026.

3 months ago - Filings

Redcare Pharmacy NV Slides: Q4 2025

Redcare Pharmacy NV has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.

3 months ago - Filings

German online drug retailer Redcare Pharmacy names Hendrik Krampe as CFO

German online drug retailer Redcare Pharmacy on Monday named Hendrik Krampe as its chief financial officer, effective December 1.

7 months ago - Reuters

Redcare Pharmacy NV Earnings Call Transcript: Q3 2025

Sales grew 27% year-over-year with strong gains in both Rx and non-Rx segments, and adjusted EBITDA margin reached 2.1% year-to-date. Cash flow and liquidity remain robust, supporting ongoing investments in logistics and automation, while full-year guidance is reiterated.

7 months ago - Transcripts

Redcare Pharmacy NV Quarterly report: Q3 2025

Redcare Pharmacy NV has published its Q3 2025 quarterly earnings report on October 30, 2025.

7 months ago - Filings

Redcare Pharmacy NV Slides: Q3 2025

Redcare Pharmacy NV has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 30, 2025.

7 months ago - Filings

Redcare Pharmacy NV Earnings Call Transcript: Q2 2025

Sales grew 27% year-over-year with record adjusted EBITDA and strong Rx momentum, especially in Germany. Guidance for over 25% sales growth and 2–2.5% EBITDA margin is confirmed, supported by regulatory wins and robust cash flow.

11 months ago - Transcripts

Redcare Pharmacy NV Quarterly report: Q2 2025

Redcare Pharmacy NV has published its Q2 2025 quarterly earnings report on July 29, 2025.

11 months ago - Filings

Redcare Pharmacy NV Slides: Q2 2025

Redcare Pharmacy NV has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 29, 2025.

11 months ago - Filings

CTP Builds 30,000 sqm of Distribution Space for Redcare Pharmacy, Europe's Leading Online Pharmacy

AMSTERDAM--(BUSINESS WIRE)--Regulatory News: CTP, Europe's largest listed developer, owner, and manager of industrial and logistics properties by gross lettable area (GLA), today began the constructio...

1 year ago - Business Wire

Redcare Pharmacy aims for higher 2024 sales after positive annual core earnings

Redcare Pharmacy on Tuesday forecast higher sales for 2024 after the online pharmacy operator posted upbeat adjusted annual core earnings, supported by a growing number of prescription sales.

2 years ago - Reuters